Zurich Insurance To Buy 51% For Rs 4,000 Crore In Kotak General For India Foray
Zurich Insurance Co. will invest approximately Rs 4,051 crore to acquire a 51% stake in Kotak Mahindra General Insurance Co.
The parties have entered into a strategic alliance and the stake acquisition will be done through a combination of fresh growth capital and share purchase, according to an exchange filing by Kotak Mahindra Bank Ltd. on Thursday.
The amount also includes fresh growth capital of up to approximately Rs 1,609 crore. The deal is expected to be completed by June 30, 2024, subject to necessary approvals, the bank said.
After the initial acquisition, the Switzerland-headquartered firm will also acquire an additional 19% stake in the bank's subsidiary within three years.
Through this deal, Kotak Mahindra General Insurance would cease to be the bank's subsidiary, and Zurich will enter India's general insurance market.
Zurich General Insurance, a 150 year old company, is currently active in over 200 countries and territories. Gross written premiums for the first six months of 2023 stood at $13.6 billion, up 1% from last year. The company reported a group business operating profit of $3.7 billion flat compared to a year ago, in the first half of calendar year 2023. Net income after tax for the period stood at $2.5 billion, up 6% year-on-year.
The transaction also values Kotak General Insurance at approximately Rs 7,943 crore on a post-money valuation, it said.
In June, a report by Reuters suggested that early-stage negotiations between parties valued the bank's subsidiary at around $800 million and Zurich expressed its interest in either a minority or majority stake.
Shares of Kotak Mahindra Bank were trading 1.12% higher at Rs 1,743 apiece on the BSE compared to a 0.72% advance in the benchmark Sensex at 10.34 a.m.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.